Navigation Links
One IV treatment a year rather than a pill a day

One IV treatment a year may prevent osteoporosis. The research involves a drug called zoledronic acid, which is approved for use in cancer patients to treat a condition in which calcium seeps from the bones. The drug was found to slow the rate of bone less and increase bone density, and the effect persisted for at least a year after treatment, long after the medication had disappeared from the blood.//

It will be about five years before doctors know whether the drug really does prevent fractures, because the study was only a one-year look at the medicine's effect on bone itself. The manufacturer, which paid for the research, has already begun the much larger and longer studies. But doctors who treat osteoporosis are excited by the preliminary results.

However, the pills must be taken sitting or standing straight up, before eating, and the patient has to stay upright for 30 minutes without eating or drinking. Side effects include abdominal pain, nausea, heartburn and irritation of the esophagus. And research has shown that such patients often skip their pills or do not take them according to instructions. The IV treatment has fewer side effects.

The drug, sold by Novartis Pharmaceuticals Corp. as Zometa, is in a class called bisphosphonates. Two other drugs in this class are used as once-a-day pills to treat osteoporosis; one also is available as a once-a-week pill. Novartis said it does not know how much the drug is likely to cost. If a version of Zometa is approved for use against osteoporosis, it will probably be given another name.
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... , ... April 24, 2017 , ... ... they are seeking public support to bring their novel lifesaving device for the ... device packed with medical-grade sensors, specially designed to read a child’s vital signs, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... opioid overdose deaths now claim the lives of 62 Americans each day.(1) Yet ... against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... health of individuals with HIV because it is not known to have significant ... have favorable effects to both lower cholesterol levels and dampen inflammation in the ...
(Date:4/24/2017)... ... ... Donna Parker, L. Ac. reads all sorts of books on self-improvement ... very practical. She wanted to write a guide/workbook that would give readers step-by-step guidance ... her in writing “ A Clear Path to a Vibrant Life : 7 Simple ...
(Date:4/24/2017)... ... ... “The Saint with Trin, and Omega Station”: a triple feature offering nonstop ... published author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. He ... District teaching English. He is heavily involved in the youth group of his local ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: